Search Results

Ireland is entering a 1.5 to 2 billion euro National Electronic Health Record programme with a poor record on large health IT projects. PPARS and the 2021 cyberattack were governance failures, not technology failures, and AI project tools inherit the optimism they are fed. This analysis argues that the discipline the HSE needs already exists in Irish pharma and MedTech under GAMP 5 and the FDA's Computer Software Assurance guidance.

The Government wants to raise the residency requirement for Irish citizenship from five years to eight, with language and civics tests on top. This analysis looks at who actually carries the weight of that change: the internationally trained nurses, care assistants and pharmaceutical professionals who keep Irish hospitals, nursing homes and manufacturing plants running, and how Ireland would compare with Canada, Australia and the rest of Europe.

As direct-to-patient dispensing platforms like LillyDirect expand across the UK and digital healthcare alters prescription delivery, community pharmacists in Ireland and Great Britain are adapting. This critical analysis examines the impact of mail-order platforms, recent regulatory shifts in Ireland, and how local chemists are pivoting to clinical primary care services.

The ABPI launches its updated 2026 Pharmaceutical Impact Map, revealing a £20.4bn economic contribution, 125,702 skilled jobs, and 3,658 NHS collaborations across the UK, while underscoring vital cross-border manufacturing and trade synergies with Ireland.

A commercial-grade blueprint for the Ireland-India pharma corridor under the EU-India FTA: tariffs, HPRA-CDSCO bridges, 2030 projections, policy asks.

The latest EFPIA Patients W.A.I.T. Indicator report reveals that Irish patients wait an average of 801 days to access newly approved medicines, prompting calls for an overhaul of the HSE and NCPE reimbursement processes and a dedicated mechanism for rare disease orphan drugs.

Presented at the ACI’s Annual General Meeting in Carlow by Minister Jennifer Murnane O’Connor and ACI Board member John Devlin, the new three-year strategy focuses on workforce recognition, professional development, and regulatory transitions.

As the Health Research Board (HRB) reports a record 8,798 alcohol treatment cases in 2025, Minister Murnane O’Connor has announced funding for an evidence-based digital intervention tool under the Sláintecare Integration Innovation Fund.

Met Éireann has issued a Status Yellow High Temperature Warning for Ireland. Here is everything you need to know: how to protect yourself and your family, what to eat and drink, what to keep at home, and the key precautions recommended by HSE and public health experts.

The Irish government signs major new Framework Agreements with MFI and IPHA, aiming to reduce patient wait times for innovative treatments to 180 days by 2029.

Despite encouraging growth in clinical trial activity, patients in Ireland face an average wait of 801 days for access to rare disease medicines, prompting calls for urgent systemic reform.

Canadian Prime Minister Mark Carney's landmark visit to Ireland strengthens bilateral cooperation in artificial intelligence, biomanufacturing, and resilient health systems, highlighting massive new investments in the life science sector.

The Health Service Executive (HSE) is facing intense budgetary pressure as clinical demand for GLP-1 obesity medications skyrockets. We break down the restrictive funding, the "dreadful dichotomy" of access, and the surge in illegal online sales.

A recent PwC report warns that US commercial healthcare costs will surge by 9% in 2027. We compare the driving forces behind this unprecedented American inflation with the pressures currently facing the Irish healthcare system.

A comprehensive guide for Irish pharmaceutical, MedTech, and life science professionals on the EU AI Act implementation, the European Health Data Space, cGMP compliance in an AI-driven environment, ALCOA+ in digital systems, and the practical steps organisations must take to achieve governance by design in 2026.

Middle East air route disruptions are raising costs and delaying Ireland’s pharma exports, impacting global medicine supply chains.

AI for Care The Artificial Intelligence (AI) Strategy for Healthcare in Ireland 2026-2030 AI Strategy for Healthcare Signals a New Era for Life Sciences